Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE).

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 16187480)

Published in J Gastrointest Surg on September 27, 2005

Authors

Philip W Y Chiu1, Angus C W Chan, S F Leung, H T Leong, K H Kwong, Micheal K W Li, Alex C M Au-Yeung, Sydney C S Chung, Enders K W Ng

Author Affiliations

1: Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, S.A.R.

Articles citing this

Esophageal cancer: staging system and guidelines for staging and treatment. J Thorac Dis (2014) 1.31

Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008. J Am Coll Surg (2012) 0.97

Curative treatment of oesophageal carcinoma: current options and future developments. Radiat Oncol (2011) 0.94

Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer. Br J Cancer (2014) 0.91

Minimally invasive surgery and cancer: controversies part 1. Surg Endosc (2009) 0.89

Perioperative management of esophageal cancer. Nat Rev Clin Oncol (2010) 0.87

Thoracoscopic esophagectomy in the prone position. Surg Endosc (2012) 0.84

The management of a patient with an operable carcinoma of the oesophagus. Ann R Coll Surg Engl (2009) 0.84

Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma. Radiat Oncol (2013) 0.84

Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal Cancer. Viszeralmedizin (2015) 0.82

Concomitant chemo-radiotherapy for unresectable oesophageal cancer: A mono-institutional study on 40 patients. Rep Pract Oncol Radiother (2012) 0.81

Perioperative and Palliative Chemotherapy for Esophageal Cancer. Viszeralmedizin (2015) 0.78

Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre. Radiat Oncol (2012) 0.77

Survival benefit of surgery to patients with esophageal squamous cell carcinoma. Sci Rep (2017) 0.75

Complications after oesophagectomy with possible contribution of neoadjuvant therapy including an EGFR-antibody to a fatal outcome. World J Surg Oncol (2007) 0.75

A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma. Radiat Oncol (2017) 0.75

Advances in Radiotherapy Management of Esophageal Cancer. J Clin Med (2016) 0.75

Comparative effectiveness of image-guided radiotherapy for non-operated localized esophageal squamous cell carcinoma patients receiving concurrent chemoradiotherapy: A population-based propensity score matched analysis. Oncotarget (2016) 0.75

Genetic variants of DNA repair genes predict the survival of patients with esophageal squamous cell cancer receiving platinum-based adjuvant chemotherapy. J Transl Med (2016) 0.75

Quality of life in patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy. Mol Clin Oncol (2014) 0.75

Single centre outcomes from definitive chemo-radiotherapy and single modality radiotherapy for locally advanced oesophageal cancer. J Gastrointest Oncol (2016) 0.75

Articles by these authors

Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol (2008) 4.44

Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med (2007) 4.29

The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med (2003) 3.75

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys (2004) 3.59

Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys (2005) 3.14

Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol (2002) 3.11

Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res (1999) 2.87

Randomized trial of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg (1998) 2.73

Comparison of EUS and ERCP in the investigation with suspected biliary obstruction caused by choledocholithiasis: a randomized study. Gastrointest Endosc (2007) 2.50

Fine-needle aspiration cytology of thyroid nodules--how well are we doing? Hong Kong Med J (2007) 2.45

Cholecystectomy or gallbladder in situ after endoscopic sphincterotomy and bile duct stone removal in Chinese patients. Gastroenterology (2006) 2.37

Obturator hernia revisited: a review of 12 cases in 7 years. J R Coll Surg Edinb (1997) 2.35

Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst (2005) 2.30

Use of a variable-stiffness colonoscope decreases the dose of patient-controlled sedation during colonoscopy: a randomized comparison of 3 colonoscopes. Gastrointest Endosc (2007) 2.17

A randomized study comparing laparoscopic versus open repair of perforated peptic ulcer using suture or sutureless technique. Ann Surg (1996) 2.00

Conventional versus laparoscopic surgery for acute appendicitis. Br J Surg (1993) 1.93

Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial. Gut (2003) 1.90

Small-bowel intestinal obstruction caused by an unusual internal hernia. Asian J Surg (2005) 1.89

Capsule endoscopy or angiography in patients with acute overt obscure gastrointestinal bleeding: a prospective randomized study with long-term follow-up. Am J Gastroenterol (2012) 1.88

TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci (2013) 1.84

Obturator hernia. Br J Surg (1966) 1.83

Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res (1999) 1.82

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (1995) 1.82

Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res (2006) 1.79

Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys (1996) 1.73

Diagnosis of gastric cancer by serum proteomic fingerprinting. Gastroenterology (2006) 1.71

Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck (2000) 1.71

TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci (2013) 1.66

Staging of nasopharyngeal carcinoma: suggestions for improving the current UICC/AJCC Staging System. Clin Oncol (R Coll Radiol) (2004) 1.65

Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma. Cochrane Database Syst Rev (2006) 1.58

Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography--an analysis of 659 patients. Radiother Oncol (1992) 1.52

Outpatient laparoscopic cholecystectomy in Hong Kong: patient acceptance. Surg Laparosc Endosc Percutan Tech (2001) 1.49

Premedication with orally administered midazolam in adults undergoing diagnostic upper endoscopy: a double-blind placebo-controlled randomized trial. Gastrointest Endosc (2005) 1.47

Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer (1996) 1.46

Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer (2002) 1.45

Caution on the use of altered fractionation for nasopharyngeal carcinoma. Radiother Oncol (1999) 1.43

Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res (2000) 1.42

Incidence of carotid stenosis in nasopharyngeal carcinoma patients after radiotherapy. Cancer (2001) 1.42

Kocuria kristinae infection associated with acute cholecystitis. BMC Infect Dis (2005) 1.40

Characterising atherothrombosis in Hong Kong: results of the Hong Kong data from a global atherothrombosis epidemiological survey. Hong Kong Med J (2005) 1.40

Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy. Clin Gastroenterol Hepatol (2008) 1.40

TG13 surgical management of acute cholecystitis. J Hepatobiliary Pancreat Sci (2013) 1.39

The clinical efficacy of neoadjuvant chemotherapy in squamous esophageal cancer: a prospective nonrandomized study of pulse and continuous-infusion regimens with Cisplatin and 5-Fluorouracil. Ann Surg Oncol (2002) 1.38

Perforation after endoscopic injection sclerotherapy for bleeding gastric varices. Surg Endosc (1994) 1.38

Phytobezoar: an uncommon cause of small bowel obstruction. Ann R Coll Surg Engl (1992) 1.37

Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res (2002) 1.37

Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chem (1999) 1.35

Relaxation music decreases the dose of patient-controlled sedation during colonoscopy: a prospective randomized controlled trial. Gastrointest Endosc (2002) 1.32

A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma. Ann Oncol (2011) 1.29

Late radiation injury to the temporal lobes: morphologic evaluation at MR imaging. Radiology (1999) 1.29

Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene (2004) 1.26

Randomized, double-blinded, placebo-controlled trial of intravenously administered hyoscine N-butyl bromide in patients undergoing colonoscopy with patient-controlled sedation. Gastrointest Endosc (2004) 1.25

Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res (1996) 1.21

Clinically underdetected asymptomatic and symptomatic carotid stenosis as a late complication of radiotherapy in Chinese nasopharyngeal carcinoma patients. Head Neck (2001) 1.19

The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. Br J Radiol (2008) 1.15

Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 1.14

Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord. Med Dosim (2007) 1.14

Dysphagia in treated nasopharyngeal cancer. Head Neck (2000) 1.13

Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J Pathol (2002) 1.13

Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging. Ann N Y Acad Sci (2000) 1.12

Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA. J Clin Oncol (2004) 1.11

A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res (1994) 1.10

High frequency ultrasound assessment of skin fibrosis: clinical results. Ultrasound Med Biol (2007) 1.10

Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int J Cancer (1998) 1.10

Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. Cancer Res (2000) 1.10

CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells. J Immunol (2000) 1.09

Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose. Int J Radiat Oncol Biol Phys (2000) 1.08

Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma. Int J Oncol (2003) 1.07

Epinephrine or epinephrine plus alcohol for injection of bleeding ulcers: a prospective randomized trial. Gastrointest Endosc (1996) 1.05

Diagnosis and current management of gastrojejunocolic fistula. Hong Kong Med J (2001) 1.05

Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation. Int J Cancer (1999) 1.03

Laparoscopic-assisted resection of rectosigmoid carcinoma. Immediate and medium-term results. Arch Surg (1997) 1.03

Predictors of peptic ulcer rebleeding after scheduled second endoscopy: clinical or endoscopic factors? Endoscopy (2006) 1.02

Biliary decompression by nasobiliary catheter or biliary stent in acute suppurative cholangitis: a prospective randomized trial. Gastrointest Endosc (2002) 1.02

Management of malignant esophagobronchial fistula. Surgery (1970) 1.02

Laparoscopic gastropexy for chronic gastric volvulus. Surg Endosc (1998) 1.01

Novel intertypic recombinants of epstein-barr virus in the chinese population. J Virol (2000) 1.00

Reliability of measurement of skin ultrasonic properties in vivo: a potential technique for assessing irradiated skin. Skin Res Technol (2007) 1.00

H. pylori genotypes and cytokine gene polymorphisms influence the development of gastric intestinal metaplasia in a Chinese population. Am J Gastroenterol (2006) 0.98

Allelic loss of chromosome 6q in gastric carcinoma. Diagn Mol Pathol (2003) 0.98

Prevalence and prognostic significance of tumor-associated tissue eosinophilia in nasopharyngeal carcinoma. Cancer (1996) 0.97

Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res (1996) 0.97

Carotid intima-media thickness in patients with head and neck irradiation for the treatment of nasopharyngeal carcinoma. Clin Radiol (2002) 0.97

Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Head Neck (1997) 0.97

Adding a sclerosant to endoscopic epinephrine injection in actively bleeding ulcers: a randomized trial. Gastrointest Endosc (1993) 0.96

Progress of memory function after radiation therapy in patients with nasopharyngeal carcinoma. J Neuropsychiatry Clin Neurosci (2003) 0.95

Endoscopic submucosal dissection versus local excision for early rectal neoplasms: a comparative study. Surg Endosc (2011) 0.95

Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinoma. Int J Cancer (1999) 0.95

Segmentation of nasopharyngeal carcinoma (NPC) lesions in MR images. Int J Radiat Oncol Biol Phys (2005) 0.94

Laparoscopy-assisted sigmoid colectomy for volvulus. Surg Laparosc Endosc (1997) 0.93

Single stitch laparoscopic omental patch repair of perforated peptic ulcer. J R Coll Surg Edinb (1997) 0.93

The Lewis-Tanner operation for cancer of the oesophagus. J R Coll Surg Edinb (1969) 0.93

EUS-guided rendezvous pancreaticogastrostomy in a patient with central pancreatectomy. Gastrointest Endosc (2013) 0.92

Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int J Cancer (1996) 0.92

The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol (1994) 0.91

Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial. Clin Cancer Res (2006) 0.91

Serum fatty acid, lipid profile and dietary intake of Hong Kong Chinese omnivores and vegetarians. Eur J Clin Nutr (2000) 0.91

MRI and CT of metastatic hepatocellular carcinoma causing spinal cord compression. Clin Radiol (1997) 0.90